CELLO Study to Explore Early Treatment of Multiple Sclerosis
Yale University announced today the initiation of a multicenter study aimed at treating early stage multiple sclerosis (MS). Supported by and in collaboration with Genentech, a member of the Roche Group, the study, known as “CELLO,” will investigate whether short-term treatment with ocrelizumab in patients with MRI lesions consistent with early MS without clinical disease—known as radiologic isolated syndrome—prevents the onset of symptoms.
Yale Cancer Center’s Dr. Lieping Chen Elected to Prestigious National Academy of Sciences
As one of the highest honors in the scientific field, Lieping Chen, MD, PhD, United Technologies Corporation Professor in Cancer Research, Professor of Immunobiology, Dermatology, and of Medical Oncology, and Co-Director of the Cancer Immunology Program at Yale Cancer Center, was elected to the National Academy of Sciences (NAS).
Yale Cancer Center Researchers Discover Common Mechanism Causing Autoimmune Disease and Blood Cancers
In a study by Yale Cancer Center, researchers report on the discovery of a common mechanism that promotes both autoimmune diseases and blood cancers, including the blood diseases Acute Lymphoblastic Leukemia (ALL), Chronic Lymphocytic Leukemia (CLL) and Mantle Cell Lymphoma (MCL).
YSM Students Advance COVID-19 Vaccination Efforts with Innovative Community-academic Partnerships and Advocacy
Yale School of Medicine students, in collaboration with a diverse set of other students and community members, are playing a significant role in the vaccination campaign in New Haven, in Connecticut, and nationally.